SS
ADPT icon

Sunbelt Securities’s Adaptive Biotechnologies ADPT Stock Holding History

Sunbelt Securities’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$708 Hold
51
– – ﹤0.01% 2190
2025
Q4 		$828 Hold
51
– – ﹤0.01% 2104
2025
Q3 		$763 Buy
+51
New +$621 ﹤0.01% 2121

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sunbelt Securities's ADPT Position: Q1 2026 in Review

Sunbelt Securities held its Adaptive Biotechnologies (ADPT) position steady in Q1 2026 at 51 shares worth $708. The position accounts for ﹤0.01% of the portfolio, ranked #2190.

Sunbelt Securities first reported a position in ADPT in Q3 2025 and has held it in 3 quarters since. The position peaked at $828 in Q4 2025. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Sunbelt Securities held 51 shares of Adaptive Biotechnologies worth $708 as of Q1 2026.
  • Sunbelt Securities left its Adaptive Biotechnologies share count unchanged in Q1 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2190 holding.
  • Sunbelt Securities first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Adaptive Biotechnologies position peaked at $828 in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.